Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$523K Hold
4,425
0.05% 236
2026
Q1
$529K Hold
4,425
0.06% 225
2025
Q4
$603K Hold
4,425
0.07% 210
2025
Q3
$653K Hold
4,425
0.07% 204
2025
Q2
$572K Hold
4,425
0.07% 208
2025
Q1
$529K Hold
4,425
0.07% 212
2024
Q4
$513K Hold
4,425
0.06% 209
2024
Q3
$598K Hold
4,425
0.07% 197
2024
Q2
$600K Hold
4,425
0.08% 190
2024
Q1
$572K Hold
4,425
0.08% 196
2023
Q4
$506K Sell
4,425
-75
-2% -$7.49K 0.08% 194
2023
Q3
$410K Hold
4,500
0.06% 221
2023
Q2
$507K Buy
4,500
+75
+2% +$7.93K 0.08% 205
2023
Q1
$463K Hold
4,425
0.07% 215
2022
Q4
$489K Hold
4,425
0.07% 206
2022
Q3
$387K Buy
+4,425
New +$402K 0.06% 220

Other funds holding XYL

Romano Brothers & Co's XYL Position: Q2 2026 in Review

Romano Brothers & Co held its Xylem (XYL) position steady in Q2 2026 at 4,425 shares worth $523K. The position accounts for 0.05% of the portfolio, ranked #236.

Romano Brothers & Co first reported a position in XYL in Q3 2022 and has held it in 16 quarters since. The position peaked at $653K in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Romano Brothers & Co held 4,425 shares of Xylem worth $523K as of Q2 2026.
  • Romano Brothers & Co left its Xylem share count unchanged in Q2 2026.
  • Xylem made up 0.05% of Romano Brothers & Co's portfolio in Q2 2026, its #236 holding.
  • Romano Brothers & Co first reported a position in Xylem in Q3 2022 and has held it in 16 quarters since.
  • Romano Brothers & Co's Xylem position peaked at $653K in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.